[1]黄燕红a,黄丽玲b,雷美红a,等.绝经后骨质疏松症患者血清几丁质酶壳三糖苷酶、血管活性肠肽水平与骨密度及骨代谢标志物的相关性研究[J].现代检验医学杂志,2022,37(02):179-183.[doi:10.3969/j.issn.1671-7414.2022.02.036]
　HUANG Yan-honga,HUANG Li-lingb,LEI Mei-honga,et al.Correlation between Serum Levels of Chitotriosidase1, Vasoactive Intestinal Peptide and Bone Mineral Density and Bone Turnover Indicators in Postmenopausal Osteoporosis Patients[J].Journal of Modern Laboratory Medicine,2022,37(02):179-183.[doi:10.3969/j.issn.1671-7414.2022.02.036]
点击复制

绝经后骨质疏松症患者血清几丁质酶壳三糖苷酶、血管活性肠肽水平与骨密度及骨代谢标志物的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年02期
页码:
179-183
栏目:
检验与临床
出版日期:
2022-03-15

文章信息/Info

Title:
Correlation between Serum Levels of Chitotriosidase1, Vasoactive Intestinal Peptide and Bone Mineral Density and Bone Turnover Indicators in Postmenopausal Osteoporosis Patients
文章编号:
1671-7414（2022）02-179-06
作者:
黄燕红a;  黄丽玲b;  雷美红a;  林小英a;  李哲立a
（解放军联勤保障部队第909 医院/ 厦门大学附属东南医院a. 内分泌风湿科；b. 妇产科, 福建漳州 360000）
Author(s):
HUANG Yan-honga;  HUANG Li-lingb;  LEI Mei-honga;  LIN Xiao-yinga;  LI Zhe-lia
（a. Department of Endocrinology and Rheumatology;b. Department of Obstetrics and Gynecology, 909 Hospital of Joint Service Support Force of PLA/Southeast Hospital Affiliated to Xiamen University, Fujian Zhangzhou 360000, China）
关键词:
绝经后骨质疏松症; 几丁质酶壳三糖苷酶; 血管活性肠肽; 骨密度; 骨代谢
分类号:
R591.44；R446.11
DOI:
10.3969/j.issn.1671-7414.2022.02.036
文献标志码:
A
摘要:
目的　探讨绝经后骨质疏松症（postmenopausal osteoporosis, PMOP） 患者血清几丁质酶壳三糖苷酶1（Chitortiosidase 1, CHIT1），血管活性肠肽（vasoactive intestinal peptide, VIP）水平与骨密度及骨代谢标志物的相关性。方法　纳入厦门大学附属东南医院2017 年12 月～ 2020 年12 月收治的PMOP 患者60 例为PMOP 组，取同期于医院体检的绝经后妇女60 例为对照组，比较两组血清CHIT1 和VIP 水平、腰椎L1-4 和股骨颈的骨密度、甲状旁腺素（parathyroid hormone, PTH）、I 型羧基端交联端肽胶原（type I collage cross-linked-telopeptide, CTX）和I 型前胶原氨基端前肽（procollagen I N-terminal peptide, PINP）水平，分析上述指标的相关性，观察PMOP 发生的影响因素。结果　PMOP 组血清CHIT1（9.64±2.25），CTX（0.52±0.13mg/L），PINP（60.84±23.51 mg/L） 水平高于对照组（5.83±1.26nmol/mol/h，0.25±0.07mg/L, 39.83±12.52mg/L），血清VIP（161.32±27.86 pg/ml），PTH（10.49±2.52pmol/L）水平以及腰椎L1-4（0.74±0.13g/cm2），股骨颈的骨密度（0.62±0.0.14g/cm2）低于对照组（302.61±43.92pg/ml，15.19±4.64pmol/L，1.19±0.16g/cm2，0.88±0.12g/cm2）， 差异均有统计学意义（t=6.110 ～ 21.042，均P=0.000）。PMOP 患者血清CHIT1 水平与血清PTH，腰椎L1-4，股骨颈的骨密度呈负相关（r=-0.327，-0.479，-0.485，均P ＜ 0.05），与血清CTX，PINP 水平呈正相关（r=0.482，0.423，均P ＜ 0.05），血清VIP 水平与血清PTH，腰椎L1-4，股骨颈的骨密度呈正相关（r=0.515，0.482，0.535，均P=0.000），与血清CTX，PINP 水平呈负相关（r= -0.414，-0.386，均P ＜ 0.05）。Logistic 回归分析提示，CHIT1 ＞ 7.73nmol/mol/h 是PMOP 发生的危险因素，而VIP ＞ 231.97pg/ml，腰椎L1-4 骨密度＞ 0.97g/cm? 是预防PMOP 发生的保护性因素（P ＜ 0.05）。结论　PMOP 患者血清CHIT1 水平增高，而VIP 水平降低，且二者均与腰椎L1-4，股骨颈骨密度以及骨代谢标志物有相关性，临床有望将二者作为评估PMOP 病情的辅助指标。
Abstract:
Objective　To explore the correlation between serum levels of chitotriosidase1 (CHIT1) and vasoactive intestinal peptide (VIP), bone metabolic markers and bone turnover indicators in postmenopausal osteoporosis (PMOP) patients. Methods　 60 PMOP patients admitted to the Southeast Hospital of Xiamen University from December 2017 to December 2020 were included in the PMOP group, and 60 postmenopausal women who received physical examination in the hospital during the same period were selected as the control group. The levels of serum CHIT1, VIP, lumbar L1-4, bone mineral density of femoral neck, parathyroid hormone (PTH), type I collage cross-linked-telopeptide（CTX） and procollagen Ⅰ N-terminal peptide（PINP） were compared between the two groups. The correlation of the above indexes were analyzed, and the influencing factors of PMOP were observed. Results　The levels of serum CHIT1（9.64±2.25nmol/mol/h）, CTX（0.52±0.13mg/L） and PINP （60.84±23.51mg/L） in the PMOP group were higher than those in the control group（5.83±1.26nmol/mol/h, 0.25±0.07mg/ L, 39.83±12.52mg/L）. The levels of serum VIP（161.32±27.86pg/ml）, PTH（10.49±2.52pmol/L） and bone mineral density of lumbar spine L1-4（0.74±0.13g/cm2）, femoral neck （0.62±0.0.14g/cm2） were lower than those in the control group（302.61±43.92pg/ml, 15.19±4.64pmol/L, 1.19±0.16g/cm2, 0.88±0.12g/cm2）, the differences were statistically significant (t=6.110~21.042, all P=0.000). Serum CHIT1 levels in PMOP patients were negatively correlated with serum PTH and bone mineral density of lumbar spine L1-4, femoral neck（r=-0.327, -0.479, -0.485, all P ＜ 0.05）, and positively correlated with serum CTX and PINP levels(r=0.482, 0.423, all P ＜ 0.05). Serum VIP levels were positively correlated with serum PTH and bone mineral density of lumbar spine L1-4, femoral neck(r=0.515, 0.482, 0.535, all P=0.000), and negatively correlated with serum CTX and PINP levels (r=-0.414, -0.386, all P ＜ 0.05). Logistic regression showed that CHIT1 > 7.73 nmol / mol / h was a risk factor for PMOP, while VIP > 231.97 pg / ml and lumbar spine L1-4 bone mineral density> 0.97 g/cm? were protective factors for PMOP (P<0.05). Conclusion　Serum CHIT1 levels in PMOP patients increased, while VIP levels decreased, and both of them were correlated with bone mineral density of lumbar spine L1-4, femoral neck and bone metabolic markers, which are expected to be used as auxiliary indicators in clinical evaluation of PMOP disease.

参考文献/References:

[1] PAIK J, SCOTT L J. Correction to: romosozumab: a review in postmenopausal osteoporosis[J]. Drugs & Aging, 2020, 37(11): 857-858.
[2] 毛未贤, 张萌萌, 马倩倩, 等．绝经后骨质疏松B 细 胞、T 细胞亚群、免疫调控因子与骨密度相关性研 究[J]．中国骨质疏松杂志, 2020, 26（12）：1732- 1736,1741． MAO Weixian, ZHANG Mengmeng, MA Qianqian, et al. Study on the correlation among B cells, T cell subsets, immune regulatory factors and BMD in postmenopausal osteoporosis [J]. Chinese Journal of Osteoporosis, 2020, 26(12):22-26.
[3] 白薇超, 魏珂阳, 熊露, 等. 几丁质酶和几丁质酶样 蛋白在慢性炎症疾病的研究进展[J]. 生命的化学, 2020, 40(10):1771-1780. BAI Weichao, WEI Keyang, XIONG Lu. et al. Research progress on chitinases and chitinase-like proteins in chronic inflammatory diseases [J]. Chemistry of Life, 2020, 40(10):1771-1778.
[4] 郭彦德．血管活性肠肽和NF-κB 信号通路在骨关 节炎中的作用机制[J]．基因组学与应用生物学, 2020, 39（2）：814-821． GUO Yande. Mechanism of action of vasoactive intestinal peptide and NF-κB signaling pathway in os teoar thr i t i s [ J ] . Genomics and Appl ied Biology,2020,39(2):814-821.
[5] 中华医学会骨质疏松和骨矿盐疾病分会．原发性骨 质疏松症诊疗指南(2017)[J]．中华骨质疏松和骨矿 盐疾病杂志, 2017, 10（5）：413-443． Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the diagnosis and management of primary osteoporosis( 2017) [J]. Chinese Journal of Osteoporosis and Bone Mineral Research, 2017, 10(5):413-443.
[6] 于彩霞, 巩云霏, 闫苏, 等．血清视黄醇结合蛋白4 及骨桥蛋白与绝经后骨质疏松症的相关性研究[J]. 现代检验医学杂志, 2020, 35(2):112-115,118. YU Caixia, GONG Yunfei, YAN Su. et al. Relationship between serum retinol binding protein 4 and osteopontin and postmenopausal osteoporosis [J]. Journal of Modern Laboratory Medicine, 2020, 35(2):112-115,118.
[7] MA M i n , LUO Shulin, ZHOU We i , e t a l . Bioinformatics analysis of gene expression profiles in B cells of postmenopausal osteoporosis patients[J]. Taiwanese Journal of Obstetrics and Gynecology, 2017, 56(2): 165-170.
[8] MAVRIKIOU G, PETROU P, GEORGIOU T, et al. Chitotriosidase deficiency in the Cypriot population: Identification of a novel deletion in the CHIT1 gene[J]. Clinical Biochemistry, 2016, 49(12): 885-889.
[9] 何炜, 黄伟权, 叶永亮, 等. 踝关节滑液血管活性肠 肽水平与踝关节创伤性关节炎的相关性[J]. 实用医 学杂志, 2017, 33(17):2853-2857. HE Wei, HUANG Weiquan, YE Yongliang, et al. Association of synovial fluid vasoactive intestinal peptide levels with disease severity of ankle posttraumatic osteoarthritis: A preliminary study [J]. The Journal of Practical Medicine, 2017, 33(17):2853-2857.
[10] KRECAK I, GVERIC-KRECAK V, RONCEVIC P, et al. Serum chitotriosidase: a circulating biomarker in polycythemia vera[J]. Hematology (Amsterdam, Netherlands), 2018, 23(10): 793-802.
[11] LARSEN T, YOSHIMURA Y, VOLDBORG B G, et al. Human chitotriosidase CHIT1 cross reacts with mammalian-like substrates[J]. FEBS Letters, 2014, 588(5): 746-751.
[12] 王伟舟, 郭皓, 袁勇. 自噬在绝经后骨质疏松中作 用的研究进展[J]. 中国骨质疏松杂志, 2017, 23 (12): 1675-1680． WANG Weizhou, GUO Hao, YUAN Yong. Research progress on the role of autophagy in postmenopausal osteoporosis [J]. Chinese Journal of Osteoporosis , 2017, 23(12):1675-1680.
[13] ZHANG Rui, LEEPER C N, WANG Xiaofei, et al. Immunomodulatory vasoactive intestinal peptide amphiphile micelles [J]. Biomaterials Science, 2018, 6(7): 1717-1722.
[14] 姚颖, 刘玮. 骨代谢生化指标与绝经后骨质疏松 性腰椎骨折的关系[J]. 实用临床医药杂志, 2020, 24(7):112-115. YAO Ying, LIU Wei. Relationship between bone metabolism biochemical indexes and osteoporotic lumbar vertebrae fracture after menopause [J]. Journal of Clinical Medicine in Practice, 2020, 24(7):112-115.
[15] 王雅纯, 周少法, 张翔．IL-33 与绝经后骨质疏松女 性骨密度和骨代谢指标相关性研究[J]．中国骨质疏 松杂志, 2020, 26（12）：1806-1809． WANG Yachun, ZHOU Shaofa, ZHANG Xiang. Correlation between serum IL-33 and bone mineral density and bone metabolism indexes in postmenopausal women with osteoporosis [J]. Chinese Journal of Osteoporosis, 2020, 26(12):1806-1809.
[16] 王玉珏, 邹倩, 郭声敏, 等．绝经后女性骨密度与骨 代谢生化指标的相关性分析[J]. 中国骨质疏松杂志, 2020, 26(3):378-381. WANG Yujue, ZOU Qian, GUO Shengmin, et al. Correlation between bone mineral density and biochemical markers of bone metabolism in postmenopausal women [J]. Chinese Journal of Osteoporosis, 2020, 26(3):378-381.
[17] 何博, 陈丰, 张卫国. 血清视黄醇与绝经后妇女骨密 度和骨代谢指标的相关性研究[J]. 中国骨质疏松杂 志, 2019, 25(10):1429-1432. HE Bo, CHEN Feng, ZHANG Weiguo. Correlation between serum retinol and bone mineral density and bone metabolism markers in postmenopausal women [J]. Chinese Journal of Osteoporosis,2019, 25(10):1429-1432.

相似文献/References:

[1]于彩霞,巩云霏,闫　苏,等.血清视黄醇结合蛋白4 及骨桥蛋白与绝经后骨质疏松症的相关性研究[J].现代检验医学杂志,2020,35(02):112.[doi:10.3969 ／ j.issn.1671-7414.2020.02.031]
　YU Cai-xia,GONG Yun-fei,YAN Su,et al.Relationship between Serum Retinol Binding Protein 4 and Osteopontin andPostmenopausal Osteoporosis[J].Journal of Modern Laboratory Medicine,2020,35(02):112.[doi:10.3969 ／ j.issn.1671-7414.2020.02.031]
[2]张恒林,吴克第,王声威,等.绝经后骨质疏松症患者血清CCL2，CX3CL1 和CXCL10 的水平表达及对骨折发生的预测价值[J].现代检验医学杂志,2024,39(04):165.[doi:10.3969/j.issn.1671-7414.2024.04.030]
　ZHANG Henglin,WU Kedi,WANG Shengwei,et al.Expression Levels of Serum CCL2, CX3CL1 and CXCL10 in Postmenopausal Osteoporosis Patients and Their Predictive Value for Fracture Occurrence[J].Journal of Modern Laboratory Medicine,2024,39(02):165.[doi:10.3969/j.issn.1671-7414.2024.04.030]

备注/Memo

备注/Memo:
基金项目：2017 年省卫生计生科技人才培养项目资助（2017CXB0128）。
作者简介：黄燕红（1985-），女，硕士研究生，主治医师，研究方向：内分泌、骨质疏松等相关疾病，E-mail:hyhong85@163.com。
通讯作者：黄丽玲（1985-），女，研究方向：内分泌、不孕不育等相关疾病，E-mail:543820090@qq.com。
更新日期/Last Update: 1900-01-01